A federal court docket remaining 12 months put the kibosh on a deal wherein Allergan transferred to the tribe the Restasis patents, which the tribe then approved again to Allergan, announcing tribal sovereign immunity to have generic firms’ problem to the patents pushed aside.



Supply hyperlink

LEAVE A REPLY

Please enter your comment!
Please enter your name here